CGS Share Price

Open 1.08 Change Price %
High 1.08 1 Day 0.00 0.00
Low 1.08 1 Week 0.02 1.89
Close 1.08 1 Month 0.01 0.93
Volume 7252 1 Year 0.68 170.00
52 Week High 1.37
52 Week Low 0.38
CGS Important Levels
Resistance 2 1.08
Resistance 1 1.08
Pivot 1.08
Support 1 1.08
Support 2 1.08
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
AKK 0.01 0.00%
TON 0.09 -10.00%
TON 0.09 -10.00%
TON 0.09 -10.00%
FAR 0.07 0.00%
FAR 0.07 0.00%
FAR 0.07 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
OMH 0.18 28.57%
SRZ 0.05 25.00%
SRZ 0.05 25.00%
HGO 0.05 25.00%
HGO 0.05 25.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
GBA 0.02 -33.33%
DAU 0.02 -33.33%
More..

Cogstate Ltd (ASX: CGS)

CGS Technical Analysis 3
As on 7th Dec 2016 CGS Share Price closed @ 1.08 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.78 & Buy for SHORT-TERM with Stoploss of 1.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
CGS Target for December
1st Target up-side 1.23
2nd Target up-side 1.36
3rd Target up-side 1.48
1st Target down-side 0.89
2nd Target down-side 0.76
3rd Target down-side 0.64
CGS Other Details
Segment EQ
Market Capital 0.00
Sector Technology
Industry Healthcare Information Services
Offical website http://www.cogstate.com
CGS Address
CGS
255 Bourke Street
Level 2
Melbourne, VIC 3000
Australia
Phone: 61 3 9664 1300
CGS Latest News
Investor Notebook: Taking a Look at Shares of CogState Limited (ASX:CGS)   Marion Business Daily   - 06th Dec 16
Cogstate Announces New Executive Appointments for Clinical Trials and ...   Business Wire (press release)   - 29th Nov 16
Cogstate and Clinical Ink Deliver Enhanced Tablet-Based eCOA for CNS Clinical ...   Business Wire (press release)   - 25th Oct 16
Here's why the shares of CogState Limited rocketed 22% today   Motley Fool Australia   - 17th Oct 16
CogState Ltd hits $27M in revenues from cognitive tools   Proactive Investors Australia   - 20th Jul 16
CogState Limited adds to healthy sales pipeline   Proactive Investors Australia   - 18th Mar 16
Top stock picks for February   Motley Fool Australia   - 01st Feb 16
Cogstate iPad Cognitive Assessments Selected for Use in Phase IV Observational ...   Business Wire (press release)   - 18th Nov 15
Cogstate Limited clinches US$4.9M in cognitive test contracts   Proactive Investors Australia   - 27th Apr 15
PEG Ratio (5 yr expected):   Yahoo!7 News   - 31st Mar 14
Interactive Technical Analysis Chart Cogstate Ltd ( CGS ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cogstate Ltd
CGS Business Profile
CogState Limited, a multi-faceted cognitive assessment and training company, is engaged in the development and commercialization of rapid, computerized tests of cognition. It operates in three segments: Clinical Trials, Sport Market, and Primary Care Physician Market. The company offers computerized tests that are suited for relevant patient populations. It also provides DataPoint, an online data management software that enables real time central monitoring, cleaning, transfer, and analysis of clinical data; and scale management, rater training, and central monitoring services for paper and pencil neuropsychological tests, rating scales, questionnaires, and patient reported outcomes. In addition, it offers COGNIGRAM, a testing tool to assess cognition in patients; and CogState Research, a repeatable and sensitive computerized cognitive testing system designed for use in research studies. Further, the company is involved in the development of sport specific training products to assess, monitor, and improve the athletic brain. Its products and services are used by pharmaceutical, biotechnology, nutraceutical, and functional food companies to quantify the effect of disease and of drugs, devices, or other interventions on human subjects participating in clinical trials, as well as various markets, such as academic research, and concussion management for athletes. CogState Limited was founded in 1999 and is headquartered in Melbourne, Australia.